National cancer institute of Canada clinical trials group MAP.3 trial:: Evaluation of exemestane to prevent breast cancer in postmenopausal women

被引：12
|
作者：
Goss, Paul E. [1 ]
Richardson, Harriet [2 ]
Chlebowski, Rowan [3 ]
Johnston, Dianne [2 ]
Sarto, Gloria E. [4 ]
Maunsell, Elizabeth [5 ]
Ingle, James N. [6 ]
Ales-Martinez, Jose E. [7 ]
机构：
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] Queens Univ, Natl Canc Inst, Clin Trials Grp, Kingston, ON K7L 3N6, Canada
[3] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA
[4] Univ Wisconsin, Sch Med, Madison, WI 53706 USA
[5] Univ Laval, Fac Med, Unite Rech Sante Populat, Quebec City, PQ G1K 7P4, Canada
[6] Mayo Clin, Rochester, MN USA
[7] Hosp Ruber Internacl, Madrid, Spain
来源：
CLINICAL BREAST CANCER | 2007年 / 7卷 / 11期
关键词：
aromatase inhibitors; estrogen receptor; selective estrogen receptor modulators;
D O I：
10.3816/CBC.2007.n.057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：895 / 900
页数：6
相关论文
共 50 条
  • [31] Phase I clinical study of didemnin B -: A National Cancer Institute of Canada clinical trials group study
    Maroun, JA
    Stewart, D
    Verma, S
    Eisenhauer, E
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (01) : 51 - 56
  • [32] Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5
    Levine, MN
    Pritchard, KL
    Bramwell, VHC
    Shepherd, LE
    Tu, DS
    Paul, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5166 - 5170
  • [33] A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada-Clinical Trials Group Trial, MA.12)
    Bramwell, V. H. C.
    Pritchard, K. I.
    Tu, D.
    Tonkin, K.
    Vachhrajani, H.
    Vandenberg, T. A.
    Robert, J.
    Arnold, A.
    O'Reilly, S. E.
    Graham, B.
    Shepherd, L.
    ANNALS OF ONCOLOGY, 2010, 21 (02) : 283 - 290
  • [34] Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials
    Mittendorf, Elizabeth A.
    Alatrash, Gheath
    Xiao, Haile
    Clifton, G. Travis
    Murray, James L.
    Peoples, George E.
    EXPERT REVIEW OF VACCINES, 2011, 10 (06) : 755 - 774
  • [35] RANDOMIZED TRIAL OF INTERFERON MAINTENANCE IN MULTIPLE-MYELOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP
    BROWMAN, GP
    BERGSAGEL, D
    SICHERI, D
    OREILLY, S
    WILSON, KS
    RUBIN, S
    BELCH, A
    SHUSTIK, C
    BARR, R
    WALKER, I
    JAMES, K
    ZEE, B
    JOHNSTON, D
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) : 2354 - 2360
  • [36] Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group
    Viallet, J
    Stewart, D
    Shepherd, F
    Ayoub, J
    Cormier, Y
    Dipietro, N
    Steward, W
    LUNG CANCER, 1996, 15 (03) : 367 - 373
  • [37] Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
    Moore, Malcolm J.
    Goldstein, David
    Hamm, John
    Figer, Arie
    Hecht, Joel R.
    Gallinger, Steven
    Au, Heather J.
    Murawa, Pawel
    Walde, David
    Wolff, Robert A.
    Campos, Daniel
    Lim, Robert
    Ding, Keyue
    Clark, Gary
    Voskoglou-Nomikos, Theodora
    Ptasynski, Mieke
    Parulekar, Wendy
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) : 1960 - 1966
  • [38] PHASE-II STUDY OF FLUTAMIDE IN PATIENTS WITH METASTATIC BREAST-CANCER - A NATIONAL CANCER INSTITUTE OF CANADA CLINICAL-TRIALS GROUP-STUDY
    PERRAULT, DJ
    LOGAN, DM
    STEWART, DJ
    BRAMWELL, VHC
    PATERSON, AHG
    EISENHAUER, EA
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (03) : 207 - 210
  • [39] PHASE-II STUDY OF LONIDAMINE IN PATIENTS WITH METASTATIC BREAST-CANCER - A NATIONAL CANCER INSTITUTE OF CANADA CLINICAL-TRIALS GROUP-STUDY
    BAND, PR
    MAROUN, J
    PRITCHARD, K
    STEWART, D
    COPPIN, CM
    WILSON, K
    EISENHAUER, EA
    CANCER TREATMENT REPORTS, 1986, 70 (11): : 1305 - 1310
  • [40] National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer
    Seidman, Andrew D.
    Bordeleau, Louise
    Fehrenbacher, Louis
    Barlow, William E.
    Perlmutter, Jane
    Rubinstein, Lawrence
    Wedam, Suparna B.
    Hershman, Dawn L.
    Hayes, Jennifer Fallas
    Butler, Lynn Pearson
    Smith, Mary Lou
    Regan, Meredith M.
    Beaver, Julia A.
    Amiri-Kordestani, Laleh
    Rastogi, Priya
    Zujewski, Jo Anne
    Korde, Larissa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (32) : 3259 - +
12345